Paul Tappenden
- Economics and Econometrics top 1%
- Health Systems, Economic Evaluations, Quality of Life 54
- Pharmaceutical Economics and Policy 12
- Economic and Financial Impacts of Cancer 11
- Healthcare Policy and Management 11
- Oncology top 2%
- Colorectal Cancer Screening and Detection 18
- Colorectal Cancer Treatments and Studies 11
- Colorectal Cancer Surgical Treatments 10
-
- Gastric Cancer Management and Outcomes 10
- Statistics and Probability top 2%
Paul Tappenden
124 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 170
- Economics and Econometrics 1.1k
- Oncology 1.0k
- Pathology and Forensic Medicine 478
- Pulmonary and Respiratory Medicine 726
- Statistics and Probability 161
Countries citing papers authored by Paul Tappenden
This map shows the geographic impact of Paul Tappenden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Tappenden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Tappenden more than expected).
Fields of papers citing papers by Paul Tappenden
This network shows the impact of papers produced by Paul Tappenden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Tappenden. The network helps show where Paul Tappenden may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul Tappenden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2021 | 13 | |
| 4 | 2021 | 22 | |
| 5 | 2020 | 17 | |
| 6 | 2017 | 21 | |
| 7 | 2017 | 17 | |
| 8 | 2016 | 12 | |
| 9 | 2016 | 1 | |
| 10 | 2016 | 4 | |
| 11 | 2014 | 7 | |
| 12 | 2013 | 63 | |
| 13 | 2013 | 46 | |
| 14 | 2013 | 76 | |
| 15 | 2013 | 18 | |
| 16 | 2013 | 20 | |
| 17 | 2009 | 103 | |
| 18 | 2009 | 73 | |
| 19 | 2007 | 147 | |
| 20 | 2006 | 27 |
About Paul Tappenden
Paul Tappenden is a scholar working on Economics and Econometrics, Oncology and Pulmonary and Respiratory Medicine, having authored 135 papers that have together received 4.1k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (54 papers), Colorectal Cancer Screening and Detection (18 papers), Pharmaceutical Economics and Policy (12 papers), Colorectal Cancer Treatments and Studies (11 papers), Economic and Financial Impacts of Cancer (11 papers), Healthcare Policy and Management (11 papers), Colorectal Cancer Surgical Treatments (10 papers) and Gastric Cancer Management and Outcomes (10 papers). The work is most often cited by research in Economics and Econometrics (1.1k citations), Oncology (1.0k citations) and Pathology and Forensic Medicine (478 citations). Paul Tappenden has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include J. Chilcott, Christopher Carroll, Katy Cooper, Daniel Hind, Suzy Paisley, Simon Eggington, Jeremy Wight, Jonathan Karnon, Ruth Wong and Eva Kaltenthaler. Their work appears in journals such as Health Technology Assessment, PharmacoEconomics, Value in Health, International Journal of Technology Assessment in Health Care and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.